Financhill
Back

AstraZeneca PLC 10K Form

Buy
67

AZN
AstraZeneca PLC

Last Price:
68.13
Seasonality Move:
2.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AZN News And Ratings

See the #1 stock for the next 7 days that we like better than AZN

AZN Financial Statistics

Sales & Book Value

Annual Sales: $44.35B
Cash Flow: $1.24B
Price / Cash Flow: 32.4
Annual Sales: $12.06
Price / Book: 5.65

Profitability

EPS (TTM): 1.98000
Net Income (TTM): $6.16B
Gross Margin: $31.96B
Return on Equity: 17%
Return on Assets: 6.41%

AstraZeneca PLC Earnings Forecast

Key AstraZeneca PLC Financial Ratios

  • The Gross Profit Margin over the past 25 years for AZN is 72.06%.
  • The Selling, General & Administrative Expenses for AZN have been equal to 40.44% of Gross Profit Margin.
  • The Research & Development expenses have been 22.01% of Revenue.
  • The Interest Expense is 40.45% of Operating Income.
  • The Net Earning history of AZN is 7.41% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 19 years.

AstraZeneca PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Drug Manufacturers - General
Sector: Healthcare
Current Symbol: AZN
CUSIP: 046353
Website: astrazeneca.com

Debt

Debt-to-Equity Ratio: 0.77
Current Ratio: 0.87
Quick Ratio: 0.67

Price-to-Earnings

Trailing P/E Ratio: 64.59
Forward P/E Ratio: 15.89

AZN Technical Analysis vs Fundamental Analysis

Buy
67
AstraZeneca PLC (AZN) is a Buy

Is AstraZeneca PLC a Buy or a Sell?

  • AstraZeneca PLC stock is rated a Buy
    The current AstraZeneca PLC [AZN] share price is $68.14. The Score for AZN is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.